BCG solvent
Phase 3Biologic
BCG solvent is one of 36 biologic programs targeting Mortality. It is currently in Phase 3.
1
Indications
2
Total Trials
1
Active Trials
35
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
47 competitors in Mortality
#DrugCompanyPhaseTrials
1Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Lovenox
SanofiApproved
Aldactone
PfizerApproved
Coly-Mycin M
PParkedale
Approved
Zocor
OOrganon and Co
Approved
Venofer
AAmerican Regent, Inc.
Approved
Merrem
BB. Braun Medical Inc.
Approved
ZINPLAVA
Merck & Co.Approved
Prometrium
FerringPhase 3
Jardiance
Boehringer IngelheimPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for BCG solvent. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 3[1]
- Company
- BBandim Health Project